|
|||
| |||||||||||||||||||||||||||||||||||||||||
A 54-year-old man was seen in consultation at the Multidisciplinary Genitourinary Clinic of the Cancer Center of this hospital because of a recent diagnosis of prostate cancer.
Approximately 3 years earlier, the serum prostate-specific antigen (PSA) level obtained during an annual physical examination was 5.2 ng per milliliter. One month later, transrectal ultrasonography-guided biopsy of the prostate was performed; pathological examination showed no evidence of carcinoma. Repeated PSA testing was performed on multiple occasions thereafter (Table 1). Fourteen months before the consultation, examination of another ultrasonography-guided biopsy specimen of the prostate revealed no evidence of carcinoma.
|
Pathological Discussion
Observation
Selection of Potentially Curative Therapy
Surgery
Radiation
Anatomical Diagnosis
Source Information
From the Departments of Hematology–Oncology (D.S.K.), Urology (W.S.M.), Radiation Oncology (A.L.Z.), and Pathology (R.H.Y.), Massachusetts General Hospital; and the Departments of Medicine (D.S.K.), Urology (W.S.M.), Radiation Oncology (A.L.Z.), and Pathology (R.H.Y.), Harvard Medical School.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |